Denileukin diftitox for the treatment of CD25 low-expression mycosis fungoides and Sézary syndrome (Q36471121)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Denileukin diftitox for the treatment of CD25 low-expression mycosis fungoides and Sézary syndrome	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PMC publication ID

3523809

retrieved

14 August 2017

title

Denileukin diftitox for the treatment of CD25 low-expression mycosis fungoides and Sézary syndrome (English)

1 reference

stated in

Europe PubMed Central

PMC publication ID

3523809

retrieved

14 August 2017

main subject

mycosis fungoides

1 reference

based on heuristic

inferred from title

author name string

H Miles Prince

series ordinal

1

1 reference

stated in

Europe PubMed Central

PMC publication ID

3523809

retrieved

14 August 2017

Ann G Martin

series ordinal

2

1 reference

stated in

Europe PubMed Central

PMC publication ID

3523809

retrieved

14 August 2017

Elise A Olsen

series ordinal

3

1 reference

stated in

Europe PubMed Central

PMC publication ID

3523809

retrieved

14 August 2017

David P Fivenson

series ordinal

4

1 reference

stated in

Europe PubMed Central

PMC publication ID

3523809

retrieved

14 August 2017

Madeleine Duvic

series ordinal

5

1 reference

stated in

Europe PubMed Central

PMC publication ID

3523809

retrieved

14 August 2017

publication date

14 September 2012

1 reference

stated in

Europe PubMed Central

PMC publication ID

3523809

retrieved

14 August 2017

published in

Leukemia & Lymphoma

1 reference

stated in

Europe PubMed Central

PMC publication ID

3523809

retrieved

14 August 2017

volume

54

1 reference

stated in

Europe PubMed Central

PMC publication ID

3523809

retrieved

14 August 2017

issue

1

1 reference

stated in

Europe PubMed Central

PMC publication ID

3523809

retrieved

14 August 2017

page(s)

69-75

1 reference

stated in

Europe PubMed Central

PMC publication ID

3523809

retrieved

14 August 2017

cites work

Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphoma

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3523809

retrieved

30 September 2017

Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3523809

retrieved

30 September 2017

Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3523809

retrieved

30 September 2017

WHO-EORTC classification for cutaneous lymphomas

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3523809

retrieved

30 September 2017

Overview of cutaneous T-cell lymphoma: prognostic factors and novel therapeutic approaches

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3523809

retrieved

30 September 2017

Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3523809

retrieved

30 September 2017

Interleukin-2 fusion protein: an investigational therapy for interleukin-2 receptor expressing malignancies

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3523809

retrieved

28 June 2018

Report of the Committee on Staging and Classification of Cutaneous T-Cell Lymphomas

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3523809

retrieved

28 June 2018

Incidence of spontaneous remission in patients with CD25-positive mycosis fungoides/Sézary syndrome receiving placebo

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3523809

retrieved

21 September 2018

Final results from a multicenter, international, pivotal study of romidepsin in refractory cutaneous T-cell lymphoma

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3523809

retrieved

21 September 2018

CD25 expression is correlated with histological grade and response to denileukin diftitox in cutaneous T-cell lymphoma

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3523809

retrieved

21 September 2018

A modified staging classification for cutaneous T-cell lymphoma

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3523809

retrieved

21 September 2018

Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma: multinational phase II-III trial results

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3523809

retrieved

21 September 2018

Treatment of refractory peripheral T-cell lymphoma with denileukin diftitox (ONTAK)

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/22738414

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Degree of CD25 expression in T-cell lymphoma is dependent on tissue site: implications for targeted therapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/22738414

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin 2 (IL-2) receptor expression and sensitivity to diphteria fusion toxin DAB389IL-2 in cultured hematopoietic cells

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/22738414

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase III placebo-controlled trial of denileukin diftitox for patients with cutaneous T-cell lymphoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/22738414

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.3109/10428194.2012.706286

1 reference

stated in

Europe PubMed Central

PMC publication ID

3523809

retrieved

14 August 2017

PMC publication ID

3523809

1 reference

stated in

Europe PubMed Central

PMC publication ID

3523809

retrieved

14 August 2017

PubMed publication ID

22738414

1 reference

stated in

Europe PubMed Central

PMC publication ID

3523809

retrieved

14 August 2017

ResearchGate publication ID

228080757

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36471121&oldid=1633090202"